Metrics as of 10/14/2026, 08:35 AM (Berlin time), refresh in progress.
Palatin Technologies Stock
Palatin Technologies, Inc.
Company data
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- CEO
- Carl Spana
- Employees
- 25
- Market cap
- $14 M
- IPO
- 15/10/1997
- Web
- palatin.com
Palatin Technologies, Inc., a biopharmaceutical company, develops first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system in the United States. It is developing oral small molecule PL7737 MC4R agonist in preclinical studies; long-acting peptide MC4R agonists; and…
Palatin Technologies stock: price history
1D
-2.8%
1W
-16.4%
1M
-40.4%
6M
-63.5%
YTD
-48.2%
1Y
+10.1%
2Y
-81.7%
5Y
-98.5%
10Y
-98.9%
Next earnings date
Next earnings date
16/11/2026 (in 30 days)
Volatility around earnings
~17% stronger price swings than usual
Ask the agents about Palatin Technologies
Analyst assessment of Palatin Technologies
PRICE TARGET LOW
US$47.50
CONSENSUS
US$47.50
MEDIAN
US$47.50
PRICE TARGET HIGH
US$47.50
0
STRONG BUY
3
BUY
0
HOLD
0
SELL
0
STRONG SELL
3
TOTAL · Buy
As of: 13/02/2025
Palatin Technologies stock metrics
P/E
-1.45
P/B
4.46
EV/EBITDA
-0.75
RETURN ON EQUITY
-65.2%
NET MARGIN
-1,449.1%
DEBT/EQUITY
0.03
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
77.7%
FLOAT SHARES
1,383,173
AVG. DAILY VOLUME (30D)
95,812
Insider transactions (SEC)
WILLS STEPHEN T
WILLS STEPHEN T
WILLS STEPHEN T
SPANA CARL
SPANA CARL
Institutional holders
Dividends & Stock splits
Comparable stocks
Frequently asked questions about Palatin Technologies stock
What does Palatin Technologies do?
Palatin Technologies, Inc. is a company in the Healthcare sector, Biotechnology industry, headquartered in United States.
The CEO is Carl Spana, the company employs around 25 people.
The IPO was on 15/10/1997; the stock trades on NASDAQ under the ticker PTN.
What do analysts say about Palatin Technologies stock?
3 analysts rate the stock, the consensus is Buy (as of 13/02/2025).
The average price target is US$47.50, ranging from US$47.50 to US$47.50, with a median of US$47.50.
This is an external assessment, not a statement by Market Jury.
When does Palatin Technologies report next?
The next earnings date is 16/11/2026.
Around past earnings, price swings were roughly 17% stronger than usual.
Does Palatin Technologies pay a dividend?
No, Palatin Technologies currently does not pay a dividend.
Which stocks are comparable to Palatin Technologies?
Comparable stocks include Vertex Pharmaceuticals, Moderna, Regeneron Pharmaceuticals, Revolution Medicines, Incyte, Exelixis, Neurocrine Biosciences and Summit Therapeutics.
How can I get Palatin Technologies stock analyzed?
Clicking "Analyze stock" lets five strategies assess Palatin Technologies against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.